Our results show that BTLA and PD-1 cooperatively inhibit the activity of CD8+ T cells and are associated with resistance to PD-1/PD-L1 pathway blockade in NSCLC patients. The gene discussed is CD274; the disease is non-small cell lung carcinoma.